Similar Papers

Paper Title
Journal
Date
Author
Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections
Giovanni Ferrara ... Markus Maeurer
The American Journal of Medicine | VOL. 125
Giovanni Ferrara, et. al.Giovanni Ferrara ... Markus Maeurer
16 May 2012
Th17 cells and viral infectious diseases
...
-
, et. al. ...
25 Dec 2009
A review of immune modulators and immunotherapy in infectious diseases.
P Sangeetha Vijayan ... Joseph Xavier
Molecular and cellular biochemistry | VOL. 479
P Sangeetha Vijayan, et. al.P Sangeetha Vijayan ... Joseph Xavier
08 Sep 2023
Genome Editing Technologies as Cellular Defense Against Viral Pathogens.
Yingzi Zhang ... Mo Li
Frontiers in cell and developmental biology | VOL. 9
Yingzi Zhang, et. al.Yingzi Zhang ... Mo Li
15 Jul 2021
View more papers

More From: Turkish Journal of Immunology

Paper Title
Journal
Date
Author
The Efficacy of Chimeric Antigen Therapy in Viral Infectious Diseases: A Systematic Review of Randomized Controlled Trials
Hossein Hatami ... Hamed Ghorani
Turkish Journal of Immunology | VOL. -
Hossein Hatami, et. al.Hossein Hatami ... Hamed Ghorani
17 Jan 2025
Cyclosporin, Tacrolimus, Mycophenolic Acid, and Dexamethasone Suppress Peripheral Blood Mononuclear Cell Proliferation and Inhibit Interferon-Gamma, IL-10 and IL-13 Production In Vitro
Abdel-Rahman Youssef
Turkish Journal of Immunology | VOL. -
Abdel-Rahman YoussefAbdel-Rahman Youssef
17 Jan 2025
Correlation Between Vitamin D3 Levels, Autoantibodies, and Antibody-Related Diseases in Patients with Hashimoto’s Thyroiditis
Ali Saad Kadhim ... Abdullah Salim Al-Karawi
Turkish Journal of Immunology | VOL. -
Ali Saad Kadhim, et. al.Ali Saad Kadhim ... Abdullah Salim Al-Karawi
17 Jan 2025
Evaluation of the Anti-Cancer Efficacy of Cyclooxygenase Inhibition in Combination with Nutrient Starvation on Pancreatic Ductal Adenocarcinoma In Vitro
Ayşe Nur Çaldıran ... Başak Aru
Turkish Journal of Immunology | VOL. -
Ayşe Nur Çaldıran, et. al.Ayşe Nur Çaldıran ... Başak Aru
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.